MVM Partners
Growth-stage healthcare investor in medtech, pharma, diagnostics and digital health across Europe and North America.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Pre-seed, Seed, Series A, Series B+, Growth
- Sector focus
- Fintech, Insurtech, Biotech & Life Sciences, Hardware & Robotics
- Cheque size
- 0–€100k
- Fund size
- $500m
- Founded
- 1997
- Website
- mvm.com
MVM Partners (formerly MVM Life Science Partners) is a specialist healthcare investor set up in 1997, with teams in London, Boston and the San Francisco Bay Area. It backs growth-stage companies in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health, and can invest in both private and listed companies.
Typical commitments are $30m to $60m per company, with room for larger cheques. Its sixth fund closed at its $500m hard cap in 2022, and the firm manages more than $1bn in total.
Team
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.